Livestock Vaccine Market Revenue, Size, Share & Opportunity Analysis Report By Vaccine Type (Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others), By Technology (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Others), By Route of Administration (Oral, Parenteral, and Others), By End-user (Veterinary Hospitals, Veterinary Clinics, and Others), By Region, And Segment Forecasts, 2025 – 2032

Livestock Vaccine Market Size & Trends

The Global Internet of Things Livestock Vaccine Market size was valued at USD 6,132.40 million in 2024. The market is projected to grow from USD 6,478.27 million in 2025 to USD 9,511.69 million by 2032, exhibiting a CAGR of 5.64% during the forecast period.

Market Definition & Introduction

The current research study analyses market industry trends. The current research report covers industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and market purchasing behaviour. The growing number of companion animals, as well as initiatives by various government agencies and animal associations, are driving the expansion of this industry. Globally, the number of companion animals and their adoption rate have increased significantly. Numerous studies have found that having a companion animal is associated with increased psychological stability, less anxiety, normalised blood pressure, fewer cardiac arrhythmias, and overall better health. The increased number of pets is expected to drive up demand for pet care products and services.

The third batch of animal vaccines was received, according to an announcement made in August 2022 by the SRTF's agriculture initiative, "Support for the Recovery of Livestock Production Within Northern Aleppo- Phase II." 57,500 estimated family members of livestock ranchers in the project region, which is home to an estimated 250,000 people, will indirectly benefit from the initiative. (Source: https://reliefweb.int/report/syrian-arab-republic/srtf-agriculture-project-receives-feed-supplements)

Market Drivers

An Increase in Livestock Production is Driving the Demand for Livestock Vaccine Market.

Veterinary vaccinations improve livestock farming's total productivity while safeguarding the animals' health. To feed the world's growing population, more efficient animal production and improved access to high-quality protein are required. An FAO High-Level Expert Forum stated that a 70% increase in total food production will be required to feed the world's 9.1 billion people by 2050. In order to accomplish this goal, vaccines that protect animal health and increase supply will be essential. Additionally, the need for antimicrobials to treat infections in companion and food-producing animals will decrease due to growing concerns about antibiotic resistance associated with the introduction of antibiotics in veterinary and human medicine, as well as their ability to eradicate the thinning of organisms causing foodborne illness in humans. These factors will also contribute to the market's growth during the forecast period.

The increasing number of cattle disease outbreaks and the steadily increasing livestock population are the primary causes of the global acceptance of ruminant vaccinations, especially those for cattle. Food, milk, meat, protein, and other industrial products like leather and wool are all derived from animals. The rabies, equine influenza virus, and foot and mouth disease vaccines are the three most widely used animal vaccines.

Market Trend

Growing Demand from Consumers for Animal-Based Dietary Products to Boost the Demand in the Forecast Period.

Globally, there is an increasing demand for animal-based food products, including eggs, dairy products, pigs, poultry, cattle, veal, buffalo, mutton, lamb, and goat meat. Livestock products provide 17% of calories and 33% of protein worldwide, though the proportion varies across developed and developing countries. The robust demand for animal-based food items is anticipated to propel substantial growth in the livestock sector as a whole. In a survey to map the supply and demand for animal-based food, the Food and Agriculture Organization of the United Nations (FAO) found that demand for livestock products such as beef, milk, mutton, pork, and poultry products (eggs and chicken) is predicted to grow most rapidly in Asian countries.

COVID Impact on Livestock Vaccine Market

In late 2020, reports of COVID-19-infected farm minks were made in a number of countries, including the US and Denmark. As a result, demand for the COVID-19 animal vaccine has increased. As a result, industry participants are collaborating to develop COVID-19-protective veterinary vaccines. For instance, Zoetis is currently administering over 11,000 doses of its experimental COVID-19 vaccination to help maintain the health and welfare of Zoo animals. However, Russia registered Carnivac-Cov, the first Covid-19 vaccine for animals, in April 2021. As a result, the rising incidence of COVID-19 infections in both domestic and wild animals would support the expansion of the sector by making animal immunizations more widely accepted as a means of providing preventative healthcare for animals.

Competitive Landscape

There are several large and small animal vaccination manufacturers in this fiercely competitive market. Government-funded bulk vaccine purchases and the rapid adoption of veterinarian preventative injections are the primary factors affecting competitiveness. Additionally, well-known companies frequently use a variety of strategies, such as joint ventures, mergers and acquisitions, and the introduction of new products, in order to preserve market share and increase the variety of products they offer.

Livestock Vaccine Companies

Zoetis

Merck & Co., Inc.

Boehringer Ingelheim Animal Health

Elanco

Virbac

Phibro Animal Health Corporation

Calier

Ceva

Bimeda Biologicals

Neogen Corporation

Company Strategic Developments

In November 2023: Virbac, a French animal health company with operations in more than 100 countries, has announced that it has acquired a majority stake in Globion India Private Limited, a well-known chicken vaccines specialist in India. By expanding its current poultry portfolio, this deal will help Virbac solidify its position as India's leader in animal health.

In October 2023: An MOU was signed by the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) of The Pirbright Institute and the Vaccine and Infectious Disease Organization (VIDO) of the University of Saskatchewan (USask). To expedite innovations for livestock animal health, the MOU facilitates strong collaboration and training in the area of vaccine manufacture.

Segment Analysis

Livestock Vaccine Market, by Vaccine Type

The bovine vaccine segment is expected to dominate the livestock vaccine market. The need for bovine vaccinations is projected to be increased by the growing number of cows globally, which will accelerate segmental expansion over the course of the projection period and account for the segment share.

However, the poultry vaccine segment is expected to grow at the fastest CAGR during the forecast period. The segment's growth is due to the rising number of sick hens in the population and the growing usage of poultry vaccinations by healthcare facilities to prevent outbreaks of diseases linked to poultry. During the projection, these factors are expected to accelerate segmental growth.

Livestock Vaccine Market, by Technology

The live attenuated vaccines segment is expected to dominate the livestock vaccine market. The size of the market is due to the rising prevalence of farm animal diseases and the high demand for this product, especially in emerging countries. Furthermore, live attenuated immunizations can strengthen and maintain an animal's immune system and effectively elicit cell-mediated immune responses. This is accomplished through the development and study of contemporary live attenuated vaccines. The development of vaccines against swine protein subunits is one of these R&D initiatives. These immunizations are administered intramuscularly. These factors are largely responsible for the rise in interest in and demand for this vaccine.

However, the recombinant vaccine segment is expected to grow at the fastest CAGR during the forecast period. This segmental expansion is the result of industry companies introducing and developing more advanced recombinant vaccines to treat the animal population. For instance, in October 2020, the U.S. animal health business of Boehringer Ingelheim International GmbH introduced VAXXITEK HVT+IBD+ILT, a recombinant vaccine that guards against three diseases in hens.

Livestock Vaccine Market, by Route of Administration

The parenterals segment is expected to dominate the livestock vaccine market. Rapid immunity onset, flexibility, established practice, and dependable immune response induction are just a few benefits of the parenteral mode of administration. Over the course of the projected period, it is expected that these benefits will cause the category to grow.

However, the oral segment is expected to grow at the fastest CAGR during the forecast period. The reasons behind the segmental expansion are the increase in clinical trials involving new and enhanced vaccines as well as the surge in various R&D projects. Furthermore, the rising introduction of vaccines by this mode of administration is expected to boost segmental expansion over the projected time.

Livestock Vaccine Market, by End-user

The veterinary clinics segment is expected to dominate the livestock vaccine market. The greater sector share is attributed by clinicians to the growing usage of livestock vaccines. Additionally, during the projected period, segmental expansion is anticipated to be supported by a growing number of veterinarians and the high amount of animals seeking care in clinics.

However, the veterinary hospitals segment is expected to grow at the fastest CAGR during the forecast period. The market is expanding because more and more animal owners are selecting veterinary facilities when post-vaccination care is required. Modern treatment facilities are also available at these institutes to help avoid issues after vaccination. Over the projected period, segmental expansion is expected to be driven by the aforementioned benefits.

Regional Analysis

According to InfoNest Market Analytics, the North American livestock vaccine market held a share of 31.25% in 2024. This significant percentage can be attributed to the high prevalence of zoonotic and cattle diseases that result in numerous animal deaths. Furthermore, since they consistently strive to broaden their global reach and commercialize innovative vaccines, a sizable number of well-known pharmaceutical companies are expected to contribute to the market's growth. The rising incidence of canine illnesses and the expanding pet population in the US are significant factors propelling the expansion of the regional market. The use of vaccines to prevent certain illnesses is growing.

The Asia Pacific livestock vaccine market is expected to register the fastest CAGR of 5.26% during the forecast period of 2025-2032. The expected rise in cattle and government initiatives, especially in developing countries, are some of the major factors expected to speed up market expansion in the region. Vaccines are therefore necessary in a country with such a large cow population. Significant R&D expenditures by several major competitors and heightened efforts to sell veterinary vaccines and inoculations at affordable prices are driving the industry.

Segmentation

Vaccine Type Outlook (Revenue, USD Million, 2019-2032)

Technology Outlook (Revenue, USD Million, 2019-2032)

Route of Administration Outlook(Revenue, USD Million, 2019-2032)

End-user Outlook(Revenue, USD Million, 2019-2032)

The Report Covers